Journal article
Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic
Abstract
Our recent randomized, placebo-controlled study in Irritable Bowel Syndrome (IBS) patients with diarrhea or alternating bowel habits showed that the probiotic Bifidobacterium longum (BL) NCC3001 improves depression scores and decreases brain emotional reactivity. However, the involved metabolic pathways remain unclear. This analysis aimed to investigate the biochemical pathways underlying the beneficial effects of BL NCC3001 using metabolomic …
Authors
Martin F-P; Cominetti O; Berger B; Combremont S; Marquis J; Xie G; Jia W; Pinto-Sanchez MI; Bercik P; Bergonzelli G
Journal
Gut Microbes, Vol. 16, No. 1,
Publisher
Taylor & Francis
Publication Date
December 31, 2024
DOI
10.1080/19490976.2024.2347715
ISSN
1949-0976